Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.™
Looking for a particular Renalytix employee's phone or email?
The Renalytix annual revenue was $520000 in 2026.
James McCullough is the Founder and Chief Executive Officer of Renalytix.
28 people are employed at Renalytix.
Renalytix is based in New York, New York.
The NAICS codes for Renalytix are [62, 621492, 5112, 62149, 6214, 511, 51, 541, 621, 54].
The SIC codes for Renalytix are [87, 873, 73, 80].